Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
Share

Pharmaceutical Outsourcing

 •  December 11

Wasdell announced a new pharmaceutical facility in Dundalk, Ireland. The facility will be a purpose built, 70,000 sq. ft, self-contained site located at the IDA Dundalk Science and Technology Park. Phase one of the build will occupy a 2.88 hectare site and represent an investment of €30M and will create 300 jobs. Wasdell also hold the land options...

Pharmaceutical Outsourcing

 •  December 4

SCA Pharmaceuticals celebrated the official opening of its 90,000 square foot manufacturing facility on November 27th, 2017. The private pharmaceutical company specializing in providing high quality sterile admixtures and prefilled syringes to hospitals and surgery centers, is located on Rainbow Road in Windsor, CT. Governor Dannel P. Malloy and...

Pharmaceutical Outsourcing

 •  November 30

AMRI has more than doubled its current bulk Active Pharmaceutical Ingredient (API) aseptic manufacturing capacity. The addition of a new multipurpose aseptic API line at AMRI's facility in Valladolid, Spain, enhances capacity at the site and complements its other aseptic API manufacturing plants in Bon Encontre and Tonneins, France. The...

Pharmaceutical Outsourcing

 •  November 29

Russian biotechnology company BIOCAD and Moroccan pharmaceutical company Sothema Labs announced the launch of medicines derived using the technology provided by the Russian manufacturer into the North African market. The manufacturing of Russian biosimilars of rituximab and bevacizumab indicated for the treatment of cancer, approved in the first...

Pharmaceutical Outsourcing

 •  November 29

bluebird bio has acquired a 125,000-square foot manufacturing facility in Durham, North Carolina. Once construction and validation is complete, the site will produce lentiviral vector for the company’s gene and cell therapies, including: Lenti-D for the treatment of cerebral adrenoleukodystrophy; LentiGlobin for the treatment of...

Pharmaceutical Outsourcing

 •  November 28

Charles River Laboratories and ENYO Pharma announced the results of a successful collaboration. The companies identified the mode of action of ENYO Pharma’s lead preclinical chemical series, EYP002, using Charles River’s newly acquired, molecular target identification tool: Capture Compound Mass Spectrometry (CCMS) technology. Molecular target...

Pharmaceutical Outsourcing

 •  November 28

Quad Technologies has opened a new, larger headquarters and laboratory that allows the company to expand manufacturing capabilities and offer clients cGMP QuickGel orders to produce reagents for gene-modified cell therapy bioprocesses. “This new headquarters changes the game for Quad Technologies and its customers,” Kevlahan said. “We are...

Pharmaceutical Outsourcing

 •  November 27

Brammer Bio announced the completion of renovations and launch of its late-stage clinical capacity and commercial-ready cGMP manufacturing site in Cambridge, Massachusetts for gene therapy products. The 66,000 square-foot Cambridge facility in the heart of Kendall Square was previously licensed by regulatory authorities to manufacture four...

Pharmaceutical Outsourcing

 •  November 22

SK Capital completed its previously announced acquisition of Perrigo Company active pharmaceutical ingredients (API) business. The API business has been renamed from Perrigo API to Wavelength Pharmaceuticals. Wavelength is a developer and manufacturer of generic APIs and finished dose forms (FDF) with primary operations located in Israel and...

Pharmaceutical Outsourcing

 •  November 17

It’s been nine weeks since Hurricane Maria made landfall on Puerto Rico and the island continues to struggle to recover from the devastation brought by this storm, as well as Hurricane Irma. As I’ve commented on previously, the medical products industry has a significant presence in Puerto Rico, and the disruption to this industry has had...